BNR
Burning Rock Biotech Ltd.
NASDAQ · Healthcare · Medical - Diagnostics & Research · CN
$14.71
+8.80%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$2.29
- Revenue estimate
- $19.1M
Latest reported
- Last report date
- Sep 10, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$2.29
- Revenue actual
- $19.9M
- Revenue estimate
- $19.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +67.4%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 10, 2026 | -$2.29 | -$0.20 | Beat 91.26% | $19.9M |
| Jun 9, 2026 | -$2.29 | -$0.20 | Beat 91.26% | $15.7M |
| Nov 20, 2025 | — | -$0.26 | — | $18.5M |
| Sep 8, 2025 | — | -$0.15 | — | $20.7M |
| Jun 6, 2025 | — | -$0.17 | — | $18.3M |
| Mar 25, 2025 | -$1.40 | -$1.08 | Beat 22.69% | $17.3M |
| Dec 3, 2024 | -$1.41 | -$0.50 | Beat 64.55% | $18.3M |
| Aug 22, 2024 | -$1.49 | -$0.14 | Beat 90.58% | $18.7M |
| May 29, 2024 | -$1.52 | -$0.16 | Beat 89.49% | $17.4M |
| Nov 30, 2023 | -$1.81 | -$2.30 | Miss -27.25% | $17.5M |
| Aug 31, 2023 | -$1.89 | -$1.80 | Beat 4.70% | $20.2M |
| May 30, 2023 | -$2.00 | -$2.60 | Miss -30.00% | $20.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026